Search earnings tickers

BMY

2024Q3BMO

Bristol-Myers Squibb Company primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2024-10-31 · Fiscal end 2024-09-30 · Features as of 2024-10-30

← Earnings history

Street

Consensus EPS1.50

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.4%

IV front—

P/C full—

P/C front—

Features as of2024-10-30

Run-up

Close—

Ret 5d-0.8%

Ret 10d-1.3%

Ret 20d-2.0%

Ret 30d+5.9%

Print

Actual EPS

1.80Beat

Estimated EPS1.50

Actual revenue

11.9B

Surprise %+20.0%

Beat / missBeat

Beat streak 42

Beat streak 82

Reaction

1-day stock reaction+3.7%

Implied vs actual

Implied 2.4%Actual 2.2%

Gap reaction+2.2%

Day result+5.9%

Next-day upYes

Realized / IV0.89×

Post tape

Post 5d-1.9%

Post 10d+4.9%

Post volume18.7M

Vol ×10d2.53×

Vol ×20d2.18×

Post range4.9%

BMY

Pre-Earnings Data